OSE Pharma SA (OSE) - Total Liabilities

Latest as of June 2025: €53.58 Million EUR ≈ $62.64 Million USD

Based on the latest financial reports, OSE Pharma SA (OSE) has total liabilities worth €53.58 Million EUR (≈ $62.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore OSE long-term investment intensity to see how much of total assets are deployed in long-term investments.

OSE Pharma SA - Total Liabilities Trend (2012–2024)

This chart illustrates how OSE Pharma SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see OSE asset base.

OSE Pharma SA Competitors by Total Liabilities

The table below lists competitors of OSE Pharma SA ranked by their total liabilities.

Company	Country	Total Liabilities
Panin Sekuritas Tbk JK:PANS	Indonesia	Rp1.28 Trillion
NS Co. Ltd KQ:217820	Korea	₩224.22 Billion
Grong Sparebank OL:GRONG	Norway	Nkr10.05 Billion
L.P.N. Development Public Company Limited BK:LPN	Thailand	฿12.24 Billion
Soonest Express Co Ltd TWO:2643	Taiwan	NT$895.08 Million
Universal Inc TW:1325	Taiwan	NT$86.23 Million
Johnson Chemical Pharmaceutical Works Co Ltd TWO:4747	Taiwan	NT$820.26 Million
Thitikorn Public Company Limited BK:TK	Thailand	฿367.52 Million

Liability Composition Analysis (2012–2024)

This chart breaks down OSE Pharma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is OSE Pharma SA's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.74	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OSE Pharma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OSE Pharma SA (2012–2024)

The table below shows the annual total liabilities of OSE Pharma SA from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	€60.15 Million ≈ $70.32 Million	+1.81%
2023-12-31	€59.08 Million ≈ $69.07 Million	-0.07%
2022-12-31	€59.12 Million ≈ $69.12 Million	+9.52%
2021-12-31	€53.99 Million ≈ $63.12 Million	+51.61%
2020-12-31	€35.61 Million ≈ $41.63 Million	+17.15%
2019-12-31	€30.40 Million ≈ $35.54 Million	+100.65%
2018-12-31	€15.15 Million ≈ $17.71 Million	-30.85%
2017-12-31	€21.91 Million ≈ $25.61 Million	-12.45%
2016-12-31	€25.02 Million ≈ $29.25 Million	+893.33%
2015-12-31	€2.52 Million ≈ $2.94 Million	-9.49%
2014-12-31	€2.78 Million ≈ $3.25 Million	+131.92%
2013-12-31	€1.20 Million ≈ $1.40 Million	+31.15%
2012-12-31	€915.00K ≈ $1.07 Million	--

About OSE Pharma SA

PA:OSE France Biotechnology

Market Cap

$68.94 Million

€58.97 Million EUR

Market Cap Rank

#20777 Global

#320 in France

Share Price

€2.63

Change (1 day)

-0.60%

52-Week Range

€2.61 - €7.20

All Time High

€15.00